Information between 19th January 2024 - 15th October 2026
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
| Non-Departmental Publications - News and Communications |
|---|
|
Jul. 28 2026
Competition and Markets Authority Source Page: Hydrocortisone tablets: alleged excessive and unfair pricing, anti-competitive agreements and abusive conduct (50277) Document: Annexes (PDF) News and Communications Found: consistent with its views on off-label use of drugs expressed to Cinven in November 2014: ‘The off-patent drugs bill |